Biomarkers as point-of-care tests to guide prescription of antibiotics in patients with acute respiratory infections in primary care

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 11, 2014, Pages

  Aabenhus, Rune ^a   Jensen, Jens Ulrik S ^a   Jørgensen, Karsten Juhl ^b   Hróbjartsson, Asbjørn ^b   Bjerrum, Lars ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; ANTIINFECTIVE AGENT;

CONSULTATION; DAILY LIFE ACTIVITY; DISEASE DURATION; DRUG EFFICACY; HOSPITAL ADMISSION; HUMAN; MORTALITY; OUTCOME ASSESSMENT; PATIENT SATISFACTION; POINT OF CARE TESTING; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RESPIRATORY TRACT INFECTION; REVIEW; SYSTEMATIC REVIEW; ACUTE DISEASE; ANTIBIOTIC RESISTANCE; BLOOD; HOSPITAL INFORMATION SYSTEM; HOSPITALIZATION; META ANALYSIS; PRIMARY HEALTH CARE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT INFECTIONS; STATISTICS AND NUMERICAL DATA;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; BIOMARKERS; C-REACTIVE PROTEIN; DRUG RESISTANCE, BACTERIAL; HOSPITALIZATION; HUMANS; POINT-OF-CARE SYSTEMS; PRIMARY HEALTH CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATORY TRACT INFECTIONS;

EID: 84939985676     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD010130.pub2     Document Type: Review

References (68)

1. Andreeva E, Melbye H. Usefulness of C-reactive protein testing in acute cough/respiratory tract infection: an open cluster-randomised clinical trial with CRP testing in the intervention group. BMC Family Practice 2014;15:80.
2. Cals JW, Butler CC, Hopstaken RM, Hood K, Dinant GJ. Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ 2009;338:b1374. [DOI: 10.1136/bmj.b1374]
3. Cals JW, Schot MJ, de Jong SA, Dinant GJ, Hopstaken RM. Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Annals of Family Medicine 2010;8(2):124-33. [DOI: 10.1370/afm.1090]
4. Diederichsen HZ, Skamling M, Diederichsen A, Grinsted P, Antonsen S, Petersen PH, et al.Randomised controlled trial of CRP rapid test as a guide to treatment of respiratory infections in general practice. Scandinavian Journal of Primary Health Care 2000;18:39-43.
5. Little P, Stuart B, Francis N, Tonkin-Crine S, Douglas E, Anthierens S, et al.The effect of web-based training in communication skills and an interactive patient booklet and the use of a CRP point of care test in acute respiratory tract infection (RTI): a multi-national cluster randomised factorial controlled trial. Lancet 2013;382(9899):1175-82.
6. Melbye H, Aaraas I, Fleten N, Kolstrup N, Mikalsen J-I. The value of C-reactive protein testing in suspected lower respiratory tract infections. A study from general practice on the effect of a rapid test on antibiotic research and course of the disease in adults [Nytten av å teste C-reaktivt protein ved mulig nedre luftveisinfeksjon. En undersøkelse fran allmennpraksis av en hurtigtests innvirkning på antibiotikaforskrivning og sykdomsforløp hos voksne]. Tidsskrift for Norske Laegeforeningen 1995;115(13):1610-5.
7. Briel M, Schuertz P, Mueller B, Young J, Schild U, Nusbarmer C, et al.Procalcitonin-guided antibiotic use vs. standard approach for acute respiratory tract infections in primary care. Archives of Internal Medicine 2008;168(18):2000-7.
8. Burkhardt O, Ewig S, Haagen U, Giersdorf S, Hartmann O, Wescheider K, et al.Procalcitonin guidance and reduction of antibiotic use in acute respiratory care. European Respiratory Journal 2010;36(3):601-7.
9. Dahler-Eriksen BS, Lauritzen T, Lassen JF, Lund ED, Brandslund I. Near-patient test for C-reactive protein in general practice: assessment of clinical, organizational, and economic outcomes. Clinical Chemistry 1999;45(4):478-85.
10. Gonzales R, Aagaard EM, Camargo CA Jr, Ma OJ, Plautz M, Maselli JH, et al.C-reactive protein testing does not decrease antibiotic use for acute cough illness when compared to a clinical algorithm. Journal of Emergency Medicine 2011;41(1):1-7.
11. Kavanagh KE, O'Shea E, Halloran R, Cantillon P, Murphy AW. A pilot study of the use of near-patient C-Reactive Protein testing in the treatment of adult respiratory tract infections in one Irish general practice. BMC Family Practice 2011;12:93.
12. Llor C, Bjerrum L, Arranz J, Garcia G, Cots JM, Gonzalez BL-V, et al.C-reactive protein testing in patients with acute rhinosinusitis leads to a reduction in antibiotic use. Family Practice 2012;29(6):653-8.
13. Takemura Y, Ebisawa K, Kakoi H, Saitoh H, Kure H, Ishida H, et al.Antibiotic selection patterns in acutely febrile new outpatients with or without immediate testing for C reactive protein and leucocyte count. Journal of Clinical Pathology 2005;58(7):729-33.
14. Converting habits of antibiotic prescribing for respiratory tract infections in German primary care (CHANGE-2). Ongoing study 10 September 2012.
15. A pilot study on the effects of adding C-reactive protein point-of-care testing in the management of acutely ill children in primary care. Ongoing study 8 July 2013.
16. Validation of a vital signs and symptoms decision tree and the effect of a point-of-care C-reactive protein test, oxygen saturation, a brief intervention and a parent leaflet on diagnosing, antibiotic prescribing rate and parental satisfaction in acutely ill children in primary care. Ongoing study January 2013.
17. Efficacy of point-of-care (POC) C-reactive protein testing to reduce inappropriate use of antibiotics for acute respiratory infections (ARIs) in the primary health care setting of Hanoi -a randomised controlled trial. Ongoing study Not yet recruiting.
18. Aabenhus R, Jensen JU. Procalcitonin-guided antibiotic treatment of respiratory tract infections in a primary care setting: are we there yet?. Primary Care Respiratory Journal 2011;20(4):360-7.
19. Adriaenssens N, Coenen S, Versporten A, Muller A, Minalu G, Faes C, et al.European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997-2009). Journal of Antimicrobial Chemotherapy 2011;66 Suppl 6:vi3-12.
20. Arnold SR, Straus SE. Interventions to improve antibiotic prescribing practices in ambulatory care. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD003539.pub2]
21. Arroll B. Antibiotics for upper respiratory tract infections: an overview of Cochrane reviews. Respiratory Medicine 2005;99(3):255-61.
22. Becker KL, Nylen ES, White JC, Muller B, Snider RH Jr. Clinical review 167: Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. Journal of Clinical Endocrinology and Metabolism 2004;89(4):1512-25.
23. Bronzwaer SL, Cars O, Buchholz U, Molstad S, Goettsch W, Veldhuijzen IK, et al.A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerging Infectious Diseases 2002;8(3):278-82.
24. Butler CC, Simpson S, Wood F. General practitioners' perceptions of introducing near-patient testing for common infections into routine primary care: a qualitative study. Scandinavian Journal of Primary Health Care 2008;26:17-21.
25. Butler CC, Hood K, Verheij T, Little P, Melbye H, Nuttall J, et al.Variation in antibiotic prescribing and its impact on recovery in patients with acute cough in primary care: prospective study in 13 countries. BMJ 2009;338:b2242.
26. Butler CC, Kelly MJ, Hood K, Schaberg T, Melbye H, Serra-Prat M, et al.Antibiotic prescribing for discoloured sputum in acute cough/lower respiratory tract infection. European Respiratory Journal 2011;38(1):119-25.
27. Butler CC, Simpson SA, Dunstan F, Rollnick S, Cohen D, Gillespie D, et al.Effectiveness of multifaceted educational programme to reduce antibiotic dispensing in primary care: practice based randomised controlled trial. BMJ 2012;344:d8173.
28. Carlet J, Collignon P, Goldmann D, Goossens H, Gyssens IC, Harbarth S, et al.Society's failure to protect a precious resource: antibiotics. Lancet 2011;378(9788):369-71.
29. Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ 2010;340:c2096.
30. Danmap. http://www.danmap.org/Downloads/Reports.aspx (accessed 17 January 2011).
31. Dinant GJ, Buntinx FF, Butler CC. The necessary shift from a diagnostic to prognostic approach. BMC Family Practice 2007;8:53.
32. Engel MF, Paling FP, Hoepelman AI, van der Meer V, Oosterheert JJ. Evaluating the evidence for the implementation of C-reactive protein measurement in adult patients with suspected lower respiratory tract infection in primary care: a systematic review. Family Practice 2011; Vol. 29:383-93.
33. Falk G, Fahey T. C-reactive protein and community-acquired pneumonia in ambulatory care: systematic review of diagnostic accuracy studies. Family Practice 2009;26(1):10-21.
34. Gjelstad S, Hoye S, Straand J, Brekke M, Dalen I, Lindbaek M. Improving antibiotic prescribing in acute respiratory tract infections: cluster randomised trial from Norwegian general practice (prescription peer academic detailing (Rx-PAD) study). BMJ 2013;347:f4403.
35. Gonzales R, Malone DC, Maselli JH, Sande MA. Excessive antibiotic use for acute respiratory infections in the United States. Clinical Infectious Diseases 2001;33(6):757-62.
36. Goossens H, Ferech M, Vander Stichele R, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005;365(9459):579-87.
37. Harnden A, Perera R, Brueggemann AB, Mayon-White R, Crook DW, Thomson A, et al.Respiratory infections for which general practitioners consider prescribing an antibiotic: a prospective study. Archives of Diseases in Childhood 2007;92(7):594-7.
38. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
39. Hoare Z, Lim WS. Pneumonia: update on diagnosis and management. BMJ 2006;332(7549):1077-9.
40. Holm A, Pedersen SS, Nexoe J, Obel N, Nielsen LP, Koldkjaer O, et al.Procalcitonin versus C-reactive protein for predicting pneumonia in adults with lower respiratory tract infection in primary care. British Journal of General Practice 2007;57(540):555-60.
41. Hopstaken RM, Muris JW, Knottnerus JA, Kester AD, Rinkens PE, Dinant GJ. Contributions of symptoms, signs, erythrocyte sedimentation rate, and C-reactive protein to a diagnosis of pneumonia in acute lower respiratory tract infection. British Journal of General Practice 2003;53(490):358-64.
42. Hopstaken RM, Stobberingh EE, Knottnerus JA, Muris JW, Nelemans P, Rinkens PE, et al.Clinical items not helpful in differentiating viral from bacterial lower respiratory tract infections in general practice. Journal of Clinical Epidemiology 2005;58(2):175-83.
43. Huang Y, Chen R, Wu T, Wei X, Guo A. Association between point-of-care CRP testing and antibiotic prescribing in respiratory tract infections: a systematic review and meta-analysis of primary care studies. British Journal of General Practice 2013;63(616):e787-94.
44. Jakobsen KA, Melbye H, Kelly MJ, Ceynowa C, Molstad S, Hood K, et al.Influence of CRP testing and clinical findings on antibiotic prescribing in adults presenting with acute cough in primary care. Scandinavian Journal of Primary Health Care 2010;28(4):229-36.
45. Kruger S, Ewig S, Papassotiriou J, Kunde J, Marre R, von Baum H, et al.Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP: results from the German competence network CAPNETZ. Respiratory Research 2009;10:65.
46. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
47. Little P, Stuart B, Moore M, Coenen S, Butler CC, Godycki-Cwirko M, et al.Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial. Lancet Infectious Disease 2013;13(2):123-9.
48. Matthys J, De Meyere M, van Driel ML, De Sutter A. Differences among international pharyngitis guidelines: not just academic. Annals of Family Medicine 2007;5(5):436-43.
49. Melbye H, Francis NA, Butler CC. Inflammatory markers are helpful when treating LRTI in primary care. Primary Care Respiratory Journal 2011;20(4):367-9.
50. Meropol SB, Localio AR, Metlay JP. Risks and benefits associated with antibiotic use for acute respiratory infections: a cohort study. Annals of Family Medicine 2013;11(2):165-72.
51. Metlay JP, Kapoor WN, Fine MJ. Does this patient have community-acquired pneumonia? Diagnosing pneumonia by history and physical examination. JAMA 1997;278(17):1440-5.
52. Pavia AT. Viral infections of the lower respiratory tract: old viruses, new viruses, and the role of diagnosis. Clinical Infectious Diseases 2011;52(Suppl 4):284-9.
53. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
54. Sande-Bruinsma N, Grundmann H, Verloo D, Tiemersma E, Monen J, Goossens H, et al.Antimicrobial drug use and resistance in Europe. Emerging Infectious Diseases 2008;14(11):1722-30.
55. Schuetz P, Albrich W, Christ-Crain M, Chastre J, Mueller B. Procalcitonin for guidance of antibiotic therapy. Expert Review of Anti-Infective Therapy 2010;8(5):575-87.
56. Schuetz P, Muller B, Christ-Crain M, Stolz D, Tamm M, Bouadma L, et al.Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database of Systematic Reviews 2012, Issue 9. [DOI: 10.1002/14651858.CD007498.pub2]
57. Smith R, Coast J. The true cost of antimicrobial resistance. BMJ 2013;346:f1493.
58. Spurling GK, Del Mar CB, Dooley L, Foxlee R. Delayed antibiotics for respiratory infections. Cochrane Database of Systematic Reviews 2011, Issue 1. [DOI: 10.1002/14651858.CD004417.pub3]
59. Stanton N, Francis NA, Butler CC. Reducing uncertainty in managing respiratory tract infections in primary care. British Journal of General Practice 2010;60(581):e466-75.
60. Steurer J, Held U, Spaar A, Bausch B, Zoller M, Hunziker R, et al.A decision aid to rule out pneumonia and reduce unnecessary prescriptions of antibiotics in primary care patients with cough and fever. BMC Medicine 2011;13:56.
61. Stocks N, Faher T. Labelling of acute respiratory illness: evidence of between-practitioner variation in the UK. Family Practice 2002;19(4):375-7.
62. van der Meer V, Neven AK, van den Broek PJ, Assendelft WJ. Diagnostic value of C reactive protein in infections of the lower respiratory tract: systematic review. BMJ 2005;331(7507):26.
63. van Vugt SF, Butler CC, Hood K, Kelly MJ, Coenen S, Goossens H, et al.Predicting benign course and prolonged illness in lower respiratory tract infections: a 13 European country study in primary care. Family Practice 2011;29(2):131-8.
64. Volanakis JE. Human C-reactive protein: expression, structure, and function. Molecular Immunology 2001;38(2-3):189-97.
65. Wipf JE, Lipsky BA, Hirschmann JV, Boyko EJ, Takasugi J, Peugeot RL, et al.Diagnosing pneumonia by physical examination: relevant or relic?. Archives of Internal Medicine 1999;159(10):1082-7.
66. Wood F, Brookes-Howell L, Hood K, Cooper L, Verheij T, Goossens H, et al.An ideal test? A multi-country qualitative study of clinicians' and patients' views of point of care tests for lower respiratory tract infection in primary care. Family Practice 2011;28(6):661-9.
67. Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, et al.Guidelines for the management of adult lower respiratory tract infections--full version. Clinical Microbiology and Infection 2011;17 Suppl 6:E1-59.
68. Yardley L, Douglas E, Anthierens S, Tonkin-Crine S, Reilly O, Stuart B, et al.Evaluation of a web-based intervention to reduce antibiotic prescribing for LRTI in six European countries: quantitative process analysis of the GRACE/INTRO randomised controlled trial. Implementation Science 2013;8(1):134.